Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 2726 - 2750 of 2809 in total

S-adenosyl-L-homocysteine

5'-S-(3-Amino-3-carboxypropyl)-5'-thioadenosine. Formed from S-adenosylmethionine after transmethylation reactions.
Experimental

5-beta-D-ribofuranosylnicotinamide adenine dinucleotide

Experimental

Selenazole-4-carboxyamide-adenine dinucleotide

Experimental

5,10-Dimethylene Tetrahydromethanopterin

Experimental

C-1027 Aromatized chromophore

Experimental

Clorobiocin

Clorobiocin is an aminocoumarin antibiotic, similar to novobiocin and coumermycin A1.
Experimental

Apstatin

Experimental

METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY-3-(4-METHYLPHENYL)PROPANOYL]-D-ALANYL-D-LEUCINATE

Experimental

TT-232

Tln 232 is under investigation in clinical trial NCT00422786 (Phase II Study of CAP-232 in Patients With Refractory Metastatic Renal Cell Carcinoma).
Investigational

(9R,10R)-9-(S-glutathionyl)-10-hydroxy-9,10-dihydrophenanthrene

Experimental

Aspartyl-Adenosine-5'-Monophosphate

Experimental

Sinefungin

Sinefungin is a solid. This compound belongs to the purine nucleosides and analogues. These are compounds comprising a purine base attached to a sugar. The proteins that adenosyl-ornithine target include RdmB, modification methylase TaqI, rRNA (adenine-N6-)-methyltransferase, and modification methylase RsrI.
Experimental

5,6-dihydroxy-NADP

Experimental

Dephospho Coenzyme A

Experimental

Skf 107457

Experimental

N-{[(2S,3S)-3-(Ethoxycarbonyl)-2-oxiranyl]carbonyl}-L-threonyl-L-isoleucine

Experimental

PZ-128

PZ-128 has been used in trials studying the prevention and treatment of Heart Diseases, Coronary Disease, Arteriosclerosis, Vascular Diseases, and Myocardial Ischemia, among others.
Investigational

6-hydroxy-FAD

Experimental

GDP-alpha-D-mannuronic acid

Experimental

Cpad

Experimental

(9S,10S)-9-(S-glutathionyl)-10-hydroxy-9,10-dihydrophenanthrene

Experimental

Histidyl-Adenosine Monophosphate

Experimental

Adenylosuccinic acid

Experimental

ABT-510

ABT-510 is a peptide mimetic of thrombospondin-1 (TSP-1), blocks angiogenesis in vitro and in vivo, and slows tumor growth. It is developed by Abbott Laboratories for the treatment of Solid Tumors, Lymphoma and Melanoma.
Investigational

[3,5-Dibromo-4-(4-Hydroxy-3-Phenethylcarbamoyl-Phenoxy)-Phenyl]-Acetic Acid

Experimental
Displaying drugs 2726 - 2750 of 2809 in total